DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr | ₹5,062 Cr | ₹3,753 Cr |
What is the latest Net Current Assets ratio of DIVIS LABORATORIES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹8,397 Cr |
Mar2023 | ₹8,211 Cr |
Mar2022 | ₹7,156 Cr |
Mar2021 | ₹5,062 Cr |
Mar2020 | ₹3,753 Cr |
How is Net Current Assets of DIVIS LABORATORIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹8,397 Cr | 2.27 | |
Mar2023 | ₹8,211 Cr | 14.74 | |
Mar2022 | ₹7,156 Cr | 41.36 | |
Mar2021 | ₹5,062 Cr | 34.89 | |
Mar2020 | ₹3,753 Cr | - |
Compare Net Current Assets of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹156,337.0 Cr | 5.3% | 3.9% | 51.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,468.0 Cr | 3.4% | 2.2% | 13.6% | Stock Analytics | |
CIPLA | ₹122,075.0 Cr | 3.3% | 1.2% | 9.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,125.0 Cr | 4% | 6.3% | 29.2% | Stock Analytics | |
MANKIND PHARMA | ₹106,592.0 Cr | 9.9% | 18.9% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,227.9 Cr | 6.1% | 2.3% | -3.2% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 5.3% |
3.9% |
51.8% |
SENSEX | 7.5% |
7.6% |
7% |
You may also like the below Video Courses